(In-person or via telehealth) Instead or in addition to usual care (in-person visits) Key Question 12 Screening for asymptomatic CKD with eGFR and urine protein (albumin) measurement Screening for asymptomatic CAD with electrocardiogram (ECG) and calcium score Screening for asymptomatic left ventricular hypertrophy (LVH) with ECG and echocardiogram (ECHO) Screening for asymptomatic peripheral vascular disease (PVD) with carotid ultrasound (US) and ankle-brachial index (ABI) At diagnosis and whether should be repeated at certain intervals c. Comparators Key Question 1 Other method of blood pressure measurement Key Question 2 No monitoring Standard of care office blood pressure Other forms of monitoring listed in intervention Key Question 3 Standard care No intervention Wait list Active intervention unrelated to weight or blood pressure Other intervention listed in intervention column Placebo Sham surgery Different frequency or amount Key Question 4 Standard of care No intervention Wait list Active intervention unrelated to blood pressure Other intervention listed in intervention column Different frequency or amount Key Question 5 Comparator group has a different systolic blood pressure goal or range (i.e., study arms did not need to have the same blood pressure goal or the comparator was a placebo) Usual care Placebo No treatment No goal Key Question 6 Comparator group has a different diastolic blood pressure goal or range (i.e., study arms did not need to have the same blood pressure goal or the comparator was a placebo) Usual care Placebo No treatment No goal Key Question 7 Initial therapy (where comparator is from a different class than the Intervention): thiazide- type diuretics, ACEIs, CCBs, beta blockers Add-on therapy: a drug/class from list above other than initial therapy, or other drugs/ classes (e.g.